AstraZeneca’s AZD0780 is an investigational oral medication that was developed to lower low-density lipoprotein cholesterol ...
MedPage Today on MSN6d
New Frontiers at ACC Meeting: Semaglutide, INOCA, & MoreComing this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring new frontiers ...
Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure
B = structural heart disease without signs/symptoms of HF prior MI, LVH, and low LVEF, asymptomatic valvular disease above measures plus ß-blockers C = structural heart disease with prior or ...
Drugs from Ionis and Arrowhead Pharma that block ... and ultra-rare disorder familial chylomicronaemia syndrome (FCS). At ACC, Ionis reported results from the phase 3 BALANCE trial of its ...
DUBLIN and BRIDGEWATER, N.J. - Amarin Corporation plc (NASDAQ:AMRN) announced today that it will present new in vitro data on its cardiovascular drug at the upcoming American College of Cardiology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback